
    
      This is a randomized, double-masking, placebo-controlled, multicenter clinical trial. The 72
      subjects will be divided into experimental group and control group. The experimental group
      will be given Ginkgo biloba dropping pills (63mg / pill) , oral, 5 pills each time, three
      times a day. The control group will be given mimetic drug of ginkgo biloba dropping pills
      (63mg / pill) , oral, 5 pills each time, three times a day, for 12 weeks to evaluate the
      effect of Ginkgo biloba dropping pills on coronary heart disease Efficacy and safety of
      stable angina pectoris with depressive symptoms.
    
  